Literature DB >> 24439566

Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes.

Jean E Goasguen1, John M Bennett2, Barbara J Bain3, Richard Brunning4, Maria-Teresa Vallespi5, Masao Tomonaga6, Gina Zini7, Alain Renault8.   

Abstract

Studies of morphology of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) refer to the definitions produced by the French-American-British (FAB) group and by the World Health Organization expert group. To clarify some points regarding the dysgranulopoiesis that are still unclear we analyzed a series of 98 neutrophils from MDS patients with regard to granularity, nuclear segmentation, the appearance of the chromatin, the presence of giant neutrophils, and the presence of nuclear chromatin extensions. We found that cells with at least 2/3 reduction of the content of granules, Pelger-like neutrophils, dysplastic non-Pelger cells, neutrophils with abnormal clumping of the chromatin, and macropolycytes could be recognized as dysplastic and included in the 10% count recommended by these two classifications. In addition, we suggest that neutrophils with more than 4 nuclear projections could be recognized as a relevant dysplastic feature.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clumping chromatin; Granulocytic dysplasia; Hypogranularity; Macropolycytes; Nuclear projections; Pelger

Mesh:

Year:  2013        PMID: 24439566     DOI: 10.1016/j.leukres.2013.12.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

Review 1.  Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.

Authors:  Aaron C Shaver; Adam C Seegmiller
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

2.  Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.

Authors:  Hiroshi Kawabata; Kensuke Usuki; Maki Shindo-Ueda; Junya Kanda; Kaoru Tohyama; Akira Matsuda; Kayano Araseki; Tomoko Hata; Takahiro Suzuki; Hidekazu Kayano; Kei Shimbo; Shigeru Chiba; Takayuki Ishikawa; Nobuyoshi Arima; Masaharu Nohgawa; Yasushi Miyazaki; Mineo Kurokawa; Shunya Arai; Kinuko Mitani; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2019-07-29       Impact factor: 2.490

3.  Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry.

Authors:  Hiroshi Kawabata; Kaoru Tohyama; Akira Matsuda; Kayano Araseki; Tomoko Hata; Takahiro Suzuki; Hidekazu Kayano; Kei Shimbo; Yuji Zaike; Kensuke Usuki; Shigeru Chiba; Takayuki Ishikawa; Nobuyoshi Arima; Masaharu Nogawa; Akiko Ohta; Yasushi Miyazaki; Kinuko Mitani; Keiya Ozawa; Shunya Arai; Mineo Kurokawa; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2017-05-11       Impact factor: 2.490

4.  Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.

Authors:  Raphael Itzykson; Thomas Cluzeau; Matthieu Duchmann; Orianne Wagner-Ballon; Thomas Boyer; Meyling Cheok; Elise Fournier; Estelle Guerin; Laurène Fenwarth; Bouchra Badaoui; Nicolas Freynet; Emmanuel Benayoun; Daniel Lusina; Isabel Garcia; Claude Gardin; Pierre Fenaux; Cécile Pautas; Bruno Quesnel; Pascal Turlure; Christine Terré; Xavier Thomas; Juliette Lambert; Aline Renneville; Claude Preudhomme; Hervé Dombret
Journal:  Leukemia       Date:  2021-10-06       Impact factor: 11.528

5.  Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Authors:  M G Della Porta; E Travaglino; E Boveri; M Ponzoni; L Malcovati; E Papaemmanuil; G M Rigolin; C Pascutto; G Croci; U Gianelli; R Milani; I Ambaglio; C Elena; M Ubezio; M C Da Via'; E Bono; D Pietra; F Quaglia; R Bastia; V Ferretti; A Cuneo; E Morra; P J Campbell; A Orazi; R Invernizzi; M Cazzola
Journal:  Leukemia       Date:  2014-05-20       Impact factor: 11.528

Review 6.  Bloodstream infections in internal medicine.

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

Review 7.  Importance of classical morphology in the diagnosis of myelodysplastic syndrome.

Authors:  Rosangela Invernizzi; Federica Quaglia; Matteo Giovanni Della Porta
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

Review 8.  Diagnostics and Prognostication of Myelodysplastic Syndromes.

Authors:  Gina Zini
Journal:  Ann Lab Med       Date:  2017-11       Impact factor: 3.464

Review 9.  Prognostic Markers of Myelodysplastic Syndromes.

Authors:  Yuliya Andreevna Veryaskina; Sergei Evgenievich Titov; Igor Borisovich Kovynev; Tatiana Ivanovna Pospelova; Igor Fyodorovich Zhimulev
Journal:  Medicina (Kaunas)       Date:  2020-07-27       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.